Skip to main content
OpenTrials
Completed

NCT Number: NCT01053741

Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission

This research is being done to learn how seminal fluid affects the lining of the colon, and whether this might make it easier for HIV to get into the body and cause infection.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Design of effective rectal microbicides to prevent HIV infection requires an understanding of rectal HIV transmission and the location within the lower gastrointestinal (GI) tract (luminal and mucosal) of HIV (cell-free and cell-associated) following exposure to infected seminal fluid. These basic details of HIV transmission have yet to be determined in human subjects, yet they are essential to select microbicide candidates if they are to be rationally designed to achieve effective concentrations at sites of HIV transmission. Rational development of a rectal microbicide also requires an understanding of those factors that may contribute to colonic mucosal injury - potential confounders of microbicidal effect. Such factors include exposure to seminal fluid which has been shown in animal and in vitro studies to cause histologic and permeability changes that might facilitate HIV transmission.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Able to provide signed informed consent
  • Men of 21 years or older.
  • Prior history of receptive anal intercourse.
  • Laboratory values within the last 28 days:
  • Negative for HIV antibodies
  • Lymphocyte count within normal limits
  • Neutrophil count > 1,000 cells/ml
  • Cluster of Differentiation 4 (CD4) cell count > 500 cells/ml
  • Platelet count ≥ 150,000 cells/mm3
  • Prothrombin Time (PT) within normal limits
  • Partial thromboplastin time (PTT) within normal limits.
  • No childbearing intentions.

Exclusion criteria

  • Active anorectal disease or recent (3 months) anorectal surgery;
  • Diarrhea, defined as three or more loose stools per day, for at least three days prior to admission.
  • History of sleep apnea, or airway problems with previous sedation procedures.
  • History of significant adverse reaction to sedation medications.
  • Other history, including significant occupational radiation exposure, history of inflammatory bowel disease or any other diseases and lab results, such that, in the judgment of the investigator, study procedures are not considered safe for the subject's participation.

Treatment and study plan

Radiolabeled autologous seminal fluid

Biological

Autologous lymphocytes labeled with 250 microcuries In-111 and 500 microcuries Tc-99m in seminal fluid vehicle.

Radiolabeled Normosol-R

Biological

Autologous lymphocytes labeled with 250 microcuries In-111 and 500 microcuries Tc-99m in Normosol-R fluid vehicle.

Primary outcomes

  1. Epithelial Disruption Graded by a Pathologist Blinded to Study Intervention.

    Time frame: One hour

    Endoscopy will be performed to obtain biopsy specimens at baseline and following each inpatient enema exposure. Samples will be obtained at each flexible sigmoidoscopy and set aside for batch sectioning and H&E staining. Slides will be reviewed and scored by a qualified pathologist blinded to treatment assignment using a qualitative scoring system. This scoring system uses semi-quantitative scoring that focuses on acute toxicity to epithelial cell layer similar to that seen in animal studies. This is a categorical grading scale, where 0 = Epithelial surface intact;1 = <1/3 of surface denuded; 2 = 1/3 - 2/3rds of surface denuded;3 = More than 2/3rds of surface denuded.

    Six separate biopsies for each subject and each treatment intervention were analyzed in a multi-level analysis. In comparison with the baseline condition (no intervention), the odds and 95% confidence interval (CI) of having a higher epithelial denudation score were calculated for each intervention.

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Collaborators

  • amfAR, The Foundation for AIDS Research

Registry information

Official study title

The Effect of Seminal Fluid on Distal Colon Mucosal Permeability and Susceptibility to HIV Infection

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Jan 21, 2010
Registry last updated
May 25, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.